Biomedical research at Oslo University Hospital

Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic research, translational research, and clinical research.

Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.

Click here to see hierarchical division and subunit overview

Summary of publications:

Publications (original articles or review articles) published in 2014 from OUS - Department of Nephrology Rikshospitalet (Div SIMT)

23 publications found

Apeland T, Holdaas H, Mansoor MA (2014)
Kidney donors and kidney transplants have abnormal aminothiol redox status, and are at increased risk of oxidative stress and reduced redox buffer capacity
Clin Biochem, 47 (6), 378-82
DOI 10.1016/j.clinbiochem.2014.02.003, PubMed 24530370

Aulie HA, Selvaag AM, Günther A, Lilleby V, Molberg Ø, Hartmann A, Holdaas H, Flatø B (2014)
Arterial haemodynamics and coronary artery calcification in adult patients with juvenile idiopathic arthritis
Ann Rheum Dis, 74 (8), 1515-21
DOI 10.1136/annrheumdis-2013-204804, PubMed 24695010

Beitland S, Os I, Sunde K (2014)
Primary injuries and secondary organ failures in trauma patients with acute kidney injury treated with continuous renal replacement therapy
Scientifica (Cairo), 2014, 235215
DOI 10.1155/2014/235215, PubMed 25587490

Bleskestad IH, Bergrem H, Leivestad T, Hartmann A, Gøransson LG (2014)
Parathyroid hormone and clinical outcome in kidney transplant patients with optimal transplant function
Clin Transplant, 28 (4), 479-86
DOI 10.1111/ctr.12341, PubMed 25649861

Chen Z, Bouamar R, Van Schaik RH, De Fijter JW, Hartmann A, Zeier M, Budde K, Kuypers DR, Weimar W, Hesselink DA, Van Gelder T (2014)
Genetic polymorphisms in IL-2, IL-10, TGF-β1, and IL-2RB and acute rejection in renal transplant patients
Clin Transplant, 28 (6), 649-55
DOI 10.1111/ctr.12346, PubMed 24579958

Dahle DO, Jenssen T, Holdaas H, Asberg A, Soveri I, Holme I, Mjøen G, Eide IA, Pihlstrøm H, Dörje C, Halden TA, Hartmann A (2014)
Uric acid and clinical correlates of endothelial function in kidney transplant recipients
Clin Transplant, 28 (10), 1167-76
DOI 10.1111/ctr.12435, PubMed 25124959

Hirsch HH, Babel N, Comoli P, Friman V, Ginevri F, Jardine A, Lautenschlager I, Legendre C, Midtvedt K, Muñoz P, Randhawa P, Rinaldo CH, Wieszek A, ESCMID Study Group of Infection in Compromised Hosts (2014)
European perspective on human polyomavirus infection, replication and disease in solid organ transplantation
Clin Microbiol Infect, 20 Suppl 7, 74-88
DOI 10.1111/1469-0691.12538, PubMed 24476010

Holdaas H, Potena L, Saliba F (2014)
mTOR inhibitors and dyslipidemia in transplant recipients: a cause for concern?
Transplant Rev (Orlando), 29 (2), 93-102
DOI 10.1016/j.trre.2014.08.003, PubMed 25227328

Horneland R, Paulsen V, Lindahl JP, Grzyb K, Eide TJ, Lundin K, Aabakken L, Jenssen T, Aandahl EM, Foss A, Øyen O (2014)
Pancreas transplantation with enteroanastomosis to native duodenum poses technical challenges--but offers improved endoscopic access for scheduled biopsies and therapeutic interventions
Am J Transplant, 15 (1), 242-50
DOI 10.1111/ajt.12953, PubMed 25394773

Lindahl JP, Jenssen T, Hartmann A (2014)
Long-term outcomes after organ transplantation in diabetic end-stage renal disease
Diabetes Res Clin Pract, 105 (1), 14-21
DOI 10.1016/j.diabres.2014.03.004, PubMed 24698407

Lindahl JP, Reinholt FP, Eide IA, Hartmann A, Midtvedt K, Holdaas H, Dorg LT, Reine TM, Kolset SO, Horneland R, Øyen O, Brabrand K, Jenssen T (2014)
In patients with type 1 diabetes simultaneous pancreas and kidney transplantation preserves long-term kidney graft ultrastructure and function better than transplantation of kidney alone
Diabetologia, 57 (11), 2357-65
DOI 10.1007/s00125-014-3353-2, PubMed 25145544

Lunde I, Bremer S, Midtvedt K, Mohebi B, Dahl M, Bergan S, Åsberg A, Christensen H (2014)
The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients
Eur J Clin Pharmacol, 70 (6), 685-93
DOI 10.1007/s00228-014-1656-3, PubMed 24658827

Mjörnstedt L, Schwartz Sørensen S, von Zur Mühlen B, Jespersen B, Hansen JM, Bistrup C, Andersson H, Gustafsson B, Solbu D, Holdaas H (2014)
Renal function three years after early conversion from a calcineurin inhibitor to everolimus: results from a randomized trial in kidney transplantation
Transpl Int, 28 (1), 42-51
DOI 10.1111/tri.12437, PubMed 25176389

Murbraech K, Holdaas H, Massey R, Undset LH, Aakhus S (2014)
Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients: an echocardiographic substudy of the randomized controlled CENTRAL trial
Transplantation, 97 (2), 184-8
DOI 10.1097/TP.0b013e3182a92728, PubMed 24092385

Pihlstrøm H, Mjøen G, Dahle DO, Pilz S, Midtvedt K, März W, Abedini S, Holme I, Fellström B, Jardine A, Holdaas H (2014)
Symmetric dimethylarginine as predictor of graft loss and all-cause mortality in renal transplant recipients
Transplantation, 98 (11), 1219-25
DOI 10.1097/TP.0000000000000205, PubMed 24999963

Reine TM, Kolseth IB, Meen AJ, Lindahl JP, Jenssen TG, Reinholt FP, Zaia J, Shao C, Hartmann A, Kolset SO (2014)
Effects of restoring normoglycemia in type 1 diabetes on inflammatory profile and renal extracellular matrix structure after simultaneous pancreas and kidney transplantation
Diabetes Res Clin Pract, 107 (1), 46-53
DOI 10.1016/j.diabres.2014.10.006, PubMed 25467621

Reine TM, Vuong TT, Jenssen TG, Kolset SO (2014)
Serglycin secretion is part of the inflammatory response in activated primary human endothelial cells in vitro
Biochim Biophys Acta, 1840 (8), 2498-505
DOI 10.1016/j.bbagen.2014.02.002, PubMed 24513305

Robertsen I, Asberg A, Granseth T, Vethe NT, Akhlaghi F, Ghareeb M, Molden E, Reier-Nilsen M, Holdaas H, Midtvedt K (2014)
More potent lipid-lowering effect by rosuvastatin compared with fluvastatin in everolimus-treated renal transplant recipients
Transplantation, 97 (12), 1266-71
DOI 10.1097/01.TP.0000443225.66960.7e, PubMed 24521776

Skrunes R, Svarstad E, Reisæter AV, Vikse BE (2014)
Familial clustering of ESRD in the Norwegian population
Clin J Am Soc Nephrol, 9 (10), 1692-700
DOI 10.2215/CJN.01680214, PubMed 25092600

Strøm Halden TA, Åsberg A, Vik K, Hartmann A, Jenssen T (2014)
Short-term efficacy and safety of sitagliptin treatment in long-term stable renal recipients with new-onset diabetes after transplantation
Nephrol Dial Transplant, 29 (4), 926-33
DOI 10.1093/ndt/gft536, PubMed 24452849

Størset E, Holford N, Hennig S, Bergmann TK, Bergan S, Bremer S, Åsberg A, Midtvedt K, Staatz CE (2014)
Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling
Br J Clin Pharmacol, 78 (3), 509-23
DOI 10.1111/bcp.12361, PubMed 25279405

von der Lippe N, Waldum B, Brekke FB, Amro AA, Reisæter AV, Os I (2014)
From dialysis to transplantation: a 5-year longitudinal study on self-reported quality of life
BMC Nephrol, 15, 191
DOI 10.1186/1471-2369-15-191, PubMed 25465066

von der Lippe N, Waldum B, Østhus TB, Reisæter AV, Os I (2014)
Health related quality of life in patients in dialysis after renal graft loss and effect of gender
BMC Womens Health, 14 (1), 34
DOI 10.1186/1472-6874-14-34, PubMed 24580724

 
Page visits: 70653